epirubicin has been researched along with Leiomyomatosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cobellis, L; Di Re, E; Grosso, G; Quattrone, P; Raspagliesi, F | 1 |
1 other study(ies) available for epirubicin and Leiomyomatosis
| Article | Year |
|---|---|
Malignant degeneration in leiomyomatosis peritonealis disseminata.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Dacarbazine; Epirubicin; Female; Humans; Ifosfamide; Leiomyomatosis; Middle Aged; Peritoneal Neoplasms | 1996 |